C.A. Holding

Osteoprotegerin (OPG) is localized to the Weibel‐Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor

Andrew C.W. Zannettino, C.A. Holding, Peter Diamond et al. · Journal of Cellular Physiology · 2005 · 165 citations

Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFκB, RANK ligand and osteoprotegerin

Tania N. Crotti, Malcolm Smith, David M. Findlay et al. · Biomaterials · 2003 · 157 citations

Bone Morphogenic Protein, Peri-implant Bone Loss, Medicine +7

The correlation of RANK, RANKL and TNFα expression with bone loss volume and polyethylene wear debris around hip implants

C.A. Holding, David M. Findlay, Roumen Stamenkov et al. · Biomaterials · 2006 · 130 citations

Bone Disease, Orthopaedic Biomaterials, Tnfα Expression +11

The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles

Gerald J. Atkins, Katie J. Welldon, C.A. Holding et al. · Biomaterials · 2009 · 109 citations

Tissue Engineering, Mechanobiology, Polyethylene Particles +10

Effect of Healing on the Expression of Transforming Growth Factor βs and their Receptors in Chronic Venous Leg Ulcers

Allison J. Cowin, Nicholas Hatzirodos, C.A. Holding et al. · Journal of Investigative Dermatology · 2001 · 101 citations · Full text

Inflammation, Angiogenesis, Immunology +7